| Issuer | % of Class | Filed |
|---|---|---|
|
GoodRx Holdings, Inc.
13D/A
Amendment 5
GDRX · 38246G108
|
29.1% |
3/21/2025
Event 3/21/2025
|
|
GoodRx Holdings, Inc.
13D/A
Amendment 4
GDRX · 38246G108
|
32.3% |
3/18/2025
Event 3/16/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.